Skip to main content
. Author manuscript; available in PMC: 2017 Apr 26.
Published in final edited form as: Biochemistry. 2016 Apr 15;55(16):2390–2400. doi: 10.1021/acs.biochem.6b00012

Table 1.

Comparison of the inhibition of mature PRS17 and PR, and autoprocessing of TFR-PRS17 precursor at the p6pol/PRS17 site, with a panel of clinical inhibitors. The inhibitors are listed in the order of increasing Ki (decreasing affinity) for PRS17. Estimated Ki values for wild-type PR from published sources are listed here solely for comparison. Similar values from different sources were averaged. In the present work Ki values for inhibition of mature PRS17 were determined by ITC or by kinetic analysis as indicated by superscripts ITC and K, respectively.

Protease inhibitor (PI) Inhibition of PRS17Ki (nM) Inhibition of PR Ki (nM) Relative resistance (PRS17/PR) Inhibition of autoprocessing at p6pol-PRS17site IC50 (μM) Difference in inhibition [autoprocessing, IC50/mature PRS17, Ki]
APV 11 ± 3.1ITC 0.20a 55 7.5 682
DRV 50 ± 8.3ITC 0.005b 10000 15 300
ATV 70 ± 14K 0.035c 2000 15 214
LPV 73 ± 20K 0.02a,c 3650 ~60 822
IDV 810 ± 75ITC 0.25c 3240 ~50 62
NFV 5870 ± 1730K 0.36a,b,d 16300 >42 >7.2
RTV 6360 ± 1310K 0.064a,d 99380 ~105 16.5
SQV 8390 ± 2640K 0.39a,b,d 21500 >105 >12.5
a,b,c,d

Ki values are cited from references4850,30, respectively, for comparison with PRS17. Ki values cited in reference50 were determined by kinetics and the rest by ITC.